Science blog
Map of the universe years in the making
Rogue bug may cause IVF failure
Technology decodes Alhambra inscriptions
Sonar causes deafness in dolphins
GM stem cells treat autoimmune disease
Nickel crash kick-started evolution
GPS inhalers track asthma triggers
Urban design turning kids off being active
Cleaning up oil spills can be bad for fish
Fluoro sensors to monitor recycled water
First cloned camel born in Dubai
Cephalopods share common toxic armoury
New evidence of aspirin risk for elderly
Salmonella vaccine could come from space
Porpoise-like sub swims with the current
Microbes thrive on iron under the ice
Blinking tower lights could save birds
Tradition can curb climate change: meeting
Coolest brown dwarf in universe found
'Silent' heart attacks quite common: study
World's land slipping in quality
Warning over 'natural' menopause therapies
Complex life pushed back in time
Lice may suppress asthma, allergies
  New evidence of aspirin risk for elderly
Taking aspirin or similar blood-thinning medication may cause minute bleeding in the brains of older adults, say researchers from the Netherlands.

But experts add it's too soon to say whether the risk of taking aspirin outweighs the benefits in healthy older people.

Researchers from the Erasmus MC University Medical Centre, Rotterdam report online this week in the Archives of Neurology the results of a study involving 1062 patients whose average age was about 70 years old.

The researchers found that patients taking aspirin or another anticoagulant drug, carbasalate calcium, appeared more likely than patients who did not use anti-clotting drugs to have bouts of cerebral "microbleeding".

The microbleeding was detected by researchers with the aid of magnetic resonance imaging technology.

The study found that the link between the drugs and microbleeding was particularly pronounced among individuals taking aspirin at higher doses. The drug often is taken as a blood thinner by elderly people to treat or prevent heart disease.

Cerebral microbleeds - sometimes a sign of small-vessel disease and common in the elderly - occur when the walls of blood vessels in the brain become weakened.

The authors say the findings raise questions as to whether patients with cerebral microbleeds who also take aspirin or similar drugs, are at increased risk for even more severe symptomatic brain haemorrhaging.

Professor Bruce Neal, of the medicine department at the University of Sydney says the study is not strong enough to rule out the possibility that factors other than the drugs caused the observed bleeding.

For example, he says factors such as blood pressure and age also influence bleeding and further research is required to confirm that the drugs are to blame.

He also says it is important to weigh up any risks of taking aspirin against the benefits.
Risks worth benefits?

While for many patients, the beneficial effects of anti-clotting drugs for individuals at risk for heart attack and stroke typically outweigh any risks of bleeding, the authors of the Rotterdam study conclude that for some patients "this risk-benefit ratio may differ for certain drugs ... thus influencing treatment decisions."

Australian cardiologist Professor Andrew Tonkin of Monash University in Melbourne agrees.

He says the Rotterdam study is an important piece of evidence in helping to work out if aspirin should be taken routinely by healthy older people.

"It's another piece of evidence that shows aspirin is not without its risks," says Tonkin.

He says many apparently healthy people take aspirin because they believe it will be beneficial.

But, says Tonkin: "The evidence on the relative benefits and risks, particularly in the elderly, at this stage is not as robust as people might anticipate."

Tonkin is involved in a new long-term study, called ASPREE, which aims to help weigh benefits and risks of aspirin.

ASPREE is a double-blind placebo-controlled trial looking at aspirin use in apparently health people over the age of 70, which will help to confirm, or otherwise, the Rotterdam study.

Among other things, it will look at the impact of aspirin on bleeding, cancer and dementia.
Roads kill more than malaria: study
Seagrass link to seahorse upright posture
Black band disease hits Great Barrier Reef
Hobbit feet reignite debate
Lizards soak up sunshine vitamin
Canada sequences swine flu virus
Termites are a miner's best friend
'Hide and seek' costly to HIV
Giant trilobites had complex social lives
Midnight sun too much for some
More toxics added to 'dirty dozen' list
Rogue galaxies prompt rethink on Newton
Acupuncture relieves back pain: study
Blazars shed light on black hole physics
Unfaithful offspring get head start
Daydreamers might solve problems faster
Coal supply may be vastly overestimated
Science and unis are winners in the budget
Heartbeat key for blood growth in embryos
Neck pain worse for women in the office
Busty figurine a 'Paleolithic Playboy'
Plant cells help bees get a grip
Space trio to give sharper view of cosmos
Sea creatures inspire CO2 sponge
Genetic link between period onset and BMI
Researchers find bacteria in clouds
Sustainable farm research 'under threat'
Tree leaves monitor pollution levels
Stay upright during labour, say experts
Antarctic ice growth linked to ozone hole
Fires fuelling global warming: study
Methane climate shock 'less likely'
Genome map reveals cow's genetic makeup
Microbe bubble machine stores energy
Stress gives reef fish wonky ears
Swine flu remains a mystery
Perception is in the ear of the beholder
Solar wind gives asteroids a tanning
Researchers find grain's memory gene
PET bottles potential health hazard
Researchers find first common autism gene
Fossil fuel use must fall to 25%: study
'WaveRider' poised for hypersonic flight
Big cuttlefish 'at risk' from desalination
Glaciers show north-south climate divide
Mobile phones help cardiac rehab
Dancing birds feel the beat
Mushrooms may yield vitamin D bonanza
Dingoes may be a native's best friend
Dud treatments more easily spread
U2 comet dust predates solar system
Australian CO2 delay sends 'mixed message'
Visit Statistics